TEVA Latest Headlines

BioXcel files for Chapter 11, will sell assets to Teva

at seekingalpha.com (Fri, 28-Aug 6:25 AM)

Piper Sandler Keeps Their Buy Rating on Teva Pharmaceutical (TEVA)

at www.tipranks.com (Thu, 27-Aug 7:56 AM)

Teva business practices under scrutiny in Turkish antitrust probe

at seekingalpha.com (Tue, 25-Aug 12:08 PM)

FDA Grants Priority Review for Teva’s Ecopipam: A Decade-First Therapy Could Redefine Tourette Syndrome Care

Market Chameleon (Wed, 19-Aug 8:54 AM)

Teva’s Pivot to Growth Accelerates: Innovative Brands Surge 43% and 2026 Outlook Raised Despite Generics Decline

Market Chameleon (Wed, 29-Jul 11:14 AM)

Teva’s Key Brands Drive Portfolio Transformation as Innovation Pipeline Expands

Market Chameleon (Wed, 29-Jul 7:36 AM)

Teva’s TEV-‘408 Shows Strong Efficacy and Safety—Phase 2b Planned Following Positive Phase 1b Vitiligo Results

Market Chameleon (Tue, 7-Jul 8:35 AM)